Product Code: ETC343706 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
The Malaysia Quinine Market is projected to witness mixed growth rate patterns during 2025 to 2029. Growth accelerates to 9.03% in 2027, following an initial rate of 8.35%, before easing to 7.18% at the end of the period.
In the Asia region, the Quinine market in Malaysia is projected to expand at a growing growth rate of 9.03% by 2027. The largest economy is China, followed by India, Japan, Australia and South Korea.
The quinine market in Malaysia is anticipated to exhibit a stable trajectory. Quinine, known for its medicinal properties, is primarily used in the pharmaceutical sector for treating malaria. With a consistent prevalence of malaria cases in certain regions, the demand for quinine-based medications is expected to persist. Additionally, ongoing research and development efforts may lead to the discovery of new applications for quinine in the healthcare industry.
The quinine market in Malaysia is experiencing a notable upswing, primarily driven by the pharmaceutical and healthcare sectors. Quinine, known for its anti-malarial properties, is a crucial component in the production of drugs combating malaria. The increasing prevalence of malaria in certain regions of Malaysia and neighboring countries is a significant factor propelling the demand for quinine-based medications. Moreover, the rising awareness about the efficacy of quinine in treating malaria has led to a surge in its usage. The pharmaceutical industry`s continual efforts to develop more effective formulations using quinine are anticipated to further drive market growth.
The quinine market in Malaysia is tied to the pharmaceutical industry, particularly for treating malaria. Challenges include the need for reliable supply sources and potential regulatory constraints.
Quinine, primarily used in the pharmaceutical industry, saw a surge in demand during the early stages of the COVID-19 pandemic due to its potential therapeutic use against the virus. This led to supply shortages. However, as the pandemic evolved, demand stabilized. The market is expected to return to a more regular growth trajectory, driven by its use in treating malaria and other health conditions.
Quinine, primarily known for its use in the pharmaceutical industry for treating malaria, has a limited market in Malaysia. The demand for quinine is driven by the healthcare sector, and major pharmaceutical companies such as PharmaCure and MediLife are actively involved in producing quinine-based medications.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Malaysia Quinine Market Overview |
3.1 Malaysia Country Macro Economic Indicators |
3.2 Malaysia Quinine Market Revenues & Volume, 2021 & 2031F |
3.3 Malaysia Quinine Market - Industry Life Cycle |
3.4 Malaysia Quinine Market - Porter's Five Forces |
3.5 Malaysia Quinine Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
3.6 Malaysia Quinine Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Malaysia Quinine Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 Malaysia Quinine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for quinine-based products in the pharmaceutical industry due to its antimalarial properties |
4.2.2 Growing awareness about the health benefits of quinine consumption |
4.2.3 Rising prevalence of malaria and other mosquito-borne diseases in Malaysia |
4.3 Market Restraints |
4.3.1 Stringent regulations and restrictions on the import and use of quinine in certain products |
4.3.2 Fluctuating prices of quinine impacting profit margins for manufacturers |
5 Malaysia Quinine Market Trends |
6 Malaysia Quinine Market, By Types |
6.1 Malaysia Quinine Market, By Mode of Administration |
6.1.1 Overview and Analysis |
6.1.2 Malaysia Quinine Market Revenues & Volume, By Mode of Administration, 2021-2031F |
6.1.3 Malaysia Quinine Market Revenues & Volume, By Oral Administration, 2021-2031F |
6.1.4 Malaysia Quinine Market Revenues & Volume, By Intravenous Administration, 2021-2031F |
6.1.5 Malaysia Quinine Market Revenues & Volume, By Intramuscular Administration, 2021-2031F |
6.1.6 Malaysia Quinine Market Revenues & Volume, By Others, 2021-2031F |
6.2 Malaysia Quinine Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Malaysia Quinine Market Revenues & Volume, By Antimalarial, 2021-2031F |
6.2.3 Malaysia Quinine Market Revenues & Volume, By Antipyretic, 2021-2031F |
6.2.4 Malaysia Quinine Market Revenues & Volume, By Others, 2021-2031F |
6.3 Malaysia Quinine Market, By End-user |
6.3.1 Overview and Analysis |
6.3.2 Malaysia Quinine Market Revenues & Volume, By Hospitals, 2021-2031F |
6.3.3 Malaysia Quinine Market Revenues & Volume, By Clinics, 2021-2031F |
6.3.4 Malaysia Quinine Market Revenues & Volume, By Ambulatory Surgical Centers, 2021-2031F |
6.3.5 Malaysia Quinine Market Revenues & Volume, By Others, 2021-2031F |
7 Malaysia Quinine Market Import-Export Trade Statistics |
7.1 Malaysia Quinine Market Export to Major Countries |
7.2 Malaysia Quinine Market Imports from Major Countries |
8 Malaysia Quinine Market Key Performance Indicators |
8.1 Number of clinical trials utilizing quinine in Malaysia |
8.2 Percentage increase in the number of quinine-based products in the market |
8.3 Consumer awareness levels regarding quinine and its benefits |
9 Malaysia Quinine Market - Opportunity Assessment |
9.1 Malaysia Quinine Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
9.2 Malaysia Quinine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Malaysia Quinine Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 Malaysia Quinine Market - Competitive Landscape |
10.1 Malaysia Quinine Market Revenue Share, By Companies, 2024 |
10.2 Malaysia Quinine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |